Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 5.91 · gapped above the open, never looked back. High/low 6.23 at 12:15 pm ET, 6.01 at 3:15 pm ET.
Cytosorbents Corp has 4 disclosed suppliers and 4 disclosed customers. Each one is named in an SEC filing, either Cytosorbents Corp’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Avenue Capital Group agreed to loan the Company up to an aggregate of $20 million (the "Avenue Capital Commitment"), to be disbursed in two tranches.”
FILING10-K0001104659-26-036451cik 0001175151
“We previously engaged in discussions with the Brotech Corporation and its affiliate, Purolite International, Inc. (collectively referred to as "Purolite"), which had demonstrated a strong interest in being our polymer manufacturer.”
FILING10-K0001104659-26-036451cik 0001175151
“We previously engaged in discussions with the Brotech Corporation and its affiliate, Purolite International, Inc. (collectively referred to as "Purolite"), which had demonstrated a strong interest in being our polymer manufacturer.”
FILING10-K0001104659-26-036451cik 0001175151
“In 2015, we entered into a distribution agreement for CytoSorb with Aferetica s.r.l., a distributor based in Bologna, Italy that specializes in the sale of certain medical products and devices, specifically extracorporeal therapies, in the critical care, cardiac surgery and liver disease markets ("Aferetica").”
FILING10-K0001104659-26-036451cik 0001175151
“The Company has developed various multi-country distribution and/or co-marketing agreements with Fresneius Medical Care AG dating back to December 2014.”
FILING10-K0001104659-26-036451cik 0001175151
“Under the terms of this amended and restated agreement, Terumo received non-exclusive distribution rights in France to promote and sell the CytoSorb CPB procedure pack for intra-operative use during cardiac surgery at specifically named hospitals in France.”
FILING10-K0001104659-26-036451cik 0001175151
“The proceeds from the Avenue Capital Commitment were used to pay off the existing outstanding debt with Bridge Bank and were additionally used for working capital purposes and to fund general business requirements.”
FILING10-K0001104659-26-036451cik 0001175151
“In March 2021, we announced the launch of a global co-marketing agreement with B. Braun Avitum AG, one of the world's leading manufacturers of medical devices and pharmaceutical products and services, to promote the use of CytoSorb ® with B. Braun's latest OMNI ® continuous blood purification platform and OMNIset ® Plus bloodline set (set version 3.0 or higher).”
FILING10-K0001104659-26-036451cik 0001175151
Watchlist prices, news filtered to it, and its next report on your desk.
Cytosorbents Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Surgical & Medical Instruments & Apparatus
CTSO (Cytosorbents Corp) has 4 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.